(VIANEWS) – HCI Group (HCI), Celestica (CLS), MiMedx Group (MDXG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. HCI Group (HCI)
40.4% sales growth and 38.3% return on equity
HCI Group, Inc., together with its subsidiaries, engages in the property and casualty insurance, reinsurance, real estate, and information technology businesses in Florida. It provides residential insurance products, such as homeowners, fire, flood, and wind-only insurance to homeowners, condominium owners, and tenants for properties, as well as offers reinsurance programs. The company also owns and operates waterfront properties and retail shopping centers, and an office building, as well as commercial properties for investment purposes. In addition, it designs and develops web-based applications and products for mobile devices, including SAMS, an online policy administration platform; Harmony, a policy administration platform; ClaimColony, an end-to-end claims management platform; and AtlasViewer, a mapping and data visualization platform. The company was formerly known as Homeowners Choice, Inc. and changed its name to HCI Group, Inc. in May 2013. HCI Group, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Earnings Per Share
As for profitability, HCI Group has a trailing twelve months EPS of $7.62.
PE Ratio
HCI Group has a trailing twelve months price to earnings ratio of 13.62. Meaning, the purchaser of the share is investing $13.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.3%.
2. Celestica (CLS)
12.2% sales growth and 19.1% return on equity
Celestica Inc. provides hardware platform and supply chain solutions in North America, Europe, and Asia. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services. It also provides enterprise-level data communications and information processing infrastructure products, such as routers, switches, data center interconnects, servers, and storage-related products; capacitors, microprocessors, resistors, and memory modules; and power inverters, energy storage products, smart meters, and other electronic componentry. The company serves aerospace and defense, industrial, energy, healthtech, capital equipment, original equipment manufacturers (OEMs), cloud-based, and other service providers, including hyperscalers, and other companies in a range of industries. Celestica Inc. was incorporated in 1994 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Celestica has a trailing twelve months EPS of $2.68.
PE Ratio
Celestica has a trailing twelve months price to earnings ratio of 18.01. Meaning, the purchaser of the share is investing $18.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.1%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 47.3% and 26.2%, respectively.
Sales Growth
Celestica’s sales growth is 15.9% for the present quarter and 12.2% for the next.
Moving Average
Celestica’s worth is higher than its 50-day moving average of $45.34 and way above its 200-day moving average of $31.59.
Previous days news about Celestica(CLS)
- According to Zacks on Tuesday, 14 May, "Some other top-ranked stocks from the broader technology sector are AppFolio (APPF Quick QuoteAPPF – Free Report) , Alphabet (GOOGL Quick QuoteGOOGL – Free Report) and Celestica (CLS Quick QuoteCLS – Free Report) . "
- 3 reasons growth investors will love celestica (cls). According to Zacks on Thursday, 16 May, "Right now, year-over-year cash flow growth for Celestica is 19.4%, which is higher than many of its peers. ", "This combination positions Celestica well for outperformance, so growth investors may want to bet on it."
3. MiMedx Group (MDXG)
9.5% sales growth and 62.09% return on equity
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
Earnings Per Share
As for profitability, MiMedx Group has a trailing twelve months EPS of $0.43.
PE Ratio
MiMedx Group has a trailing twelve months price to earnings ratio of 14.66. Meaning, the purchaser of the share is investing $14.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.09%.
4. Global Payments (GPN)
7% sales growth and 5.91% return on equity
Global Payments Inc. provides payment technology and software solutions for card, check, and digital-based payments in the Americas, Europe, and the Asia-Pacific. It operates through two segments, Merchant Solutions and Issuer Solutions. The Merchant Solutions segment offers authorization, settlement and funding, customer support, chargeback resolution, terminal rental, sales and deployment, payment security, and consolidated billing and reporting services. This segment also provides an array of enterprise software solutions that streamline business operations of its customers in various vertical markets; and value-added solutions and services, such as point-of-sale software, analytics and customer engagement, payroll and reporting, and human capital management. The Issuer Solutions segment offers solutions that enable financial institutions and retailers to manage their card portfolios through a platform; and commercial payments, account payables, and electronic payment alternatives solutions for businesses and governments. It markets its products and services through direct sales force, trade associations, agent and enterprise software providers, referral arrangements with value-added resellers, and independent sales organizations. The company was founded in 1967 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Global Payments has a trailing twelve months EPS of $3.77.
PE Ratio
Global Payments has a trailing twelve months price to earnings ratio of 32.82. Meaning, the purchaser of the share is investing $32.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.91%.
Sales Growth
Global Payments’s sales growth is 5.2% for the ongoing quarter and 7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 11.5% and 13.8%, respectively.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 14, 2024, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 0.92%.
Previous days news about Global Payments(GPN)
- According to Zacks on Tuesday, 14 May, "Some other top-ranked stocks in the broaderBusiness Services space areMoneyLion Inc. (ML Quick QuoteML – Free Report) , Global Payments Inc.(GPN Quick QuoteGPN – Free Report) , andWEX Inc.(WEX Quick QuoteWEX – Free Report) . ", "MoneyLion sports a Zacks Rank #1 (Strong Buy), while Global Payments and WEX carry a Zacks Rank #2 at present. "
- According to Zacks on Thursday, 16 May, "While SPX Technologies sports a Zacks Rank #1 (Strong Buy), Barrett Business Services and Global Payments carry a Zacks Rank #2 (Buy), at present. ", "The bottom line of Global Payments outpaced estimates in each of the last four quarters, the average surprise being 1.14%. "
